BioPhotas Medical Device Receives FDA Clearance

BioPhotas in Tustin, Calif., announced that it has received clearance from the FDA for its biophotonic medical device for six indications-for-use.

Advertisement

The device, Celluma, can be used for treating of acne, muscle and joint stiffness, muscle spasms, arthritis symptoms and compromised local blood circulation. Celluma uses three distinct wave lengths of light energy to treat skin, muscle and joint conditions.

More Articles on Pain Management:

ASIPP: Keep Epidural & Transforaminal Injections Off National Coverage Determination List
New Jersey Bill Emphasizes Physician’s Preferred Pain Medication Over Insurers
New Pain Institute in Illinois Offers Osteoarthritis Pain Relief Program

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.